These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31031331)

  • 1. Secreted protein acidic and rich in cysteine (SPARC) induces epithelial-mesenchymal transition, enhancing migration and invasion, and is associated with high Gleason score in prostate cancer.
    López-Moncada F; Torres MJ; Castellón EA; Contreras HR
    Asian J Androl; 2019; 21(6):557-564. PubMed ID: 31031331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
    López-Moncada F; Torres MJ; Lavanderos B; Cerda O; Castellón EA; Contreras HR
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
    Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
    Jiang X; Liu F; Wang Y; Gao J
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
    Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines.
    Orellana-Serradell O; Herrera D; Castellon EA; Contreras HR
    Asian J Androl; 2018; 20(3):294-299. PubMed ID: 29271397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
    Sagredo AI; Sagredo EA; Pola V; Echeverría C; Andaur R; Michea L; Stutzin A; Simon F; Marcelain K; Armisén R
    J Cell Physiol; 2019 Mar; 234(3):2037-2050. PubMed ID: 30343491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of Secreted Protein, Acidic and Rich in Cysteine in Prostate Carcinogenesis: Development of a 3D Nanostructured Bone-Like Model.
    Ribeiro N; Costa-Pinheiro P; Henrique R; Gomez-Lazaro M; Pereira MP; Mansur AAP; Mansur HS; Jerónimo C; Sousa SR; Monteiro FJ
    J Biomed Nanotechnol; 2016 Aug; 12(8):1667-78. PubMed ID: 29342345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells.
    Sun W; Feng J; Yi Q; Xu X; Chen Y; Tang L
    Biofactors; 2018 Sep; 44(5):453-464. PubMed ID: 30346081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
    Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
    J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.
    Girotti MR; Fernández M; López JA; Camafeita E; Fernández EA; Albar JP; Benedetti LG; Valacco MP; Brekken RA; Podhajcer OL; Llera AS
    J Invest Dermatol; 2011 Dec; 131(12):2438-47. PubMed ID: 21850018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
    Yang F; Yu N; Wang H; Zhang C; Zhang Z; Li Y; Li D; Yan L; Liu H; Xu Z
    PLoS One; 2018; 13(1):e0190725. PubMed ID: 29300772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
    Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
    Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
    Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S
    Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPARC enhances 5-FU chemosensitivity in gastric cancer by modulating epithelial-mesenchymal transition and apoptosis.
    Ma J; Ma Y; Chen S; Guo S; Hu J; Yue T; Zhang J; Zhu J; Wang P; Chen G; Liu Y
    Biochem Biophys Res Commun; 2021 Jun; 558():134-140. PubMed ID: 33910127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer.
    Hung JY; Yen MC; Jian SF; Wu CY; Chang WA; Liu KT; Hsu YL; Chong IW; Kuo PL
    Oncotarget; 2017 Sep; 8(38):63691-63702. PubMed ID: 28969021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-mediated expression of SPARC is correlated with tumor progression and poor prognosis of breast cancer.
    Li XL; Li JL; Qiu DJ; Ma L
    Neoplasma; 2022 Jul; 69(4):794-806. PubMed ID: 35400166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer.
    Liu T; Qiu X; Zhao X; Yang R; Lian H; Qu F; Li X; Guo H
    Oncol Rep; 2018 Feb; 39(2):659-666. PubMed ID: 29207175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.